PharmaLectures.com

Courses › Pharma training by country › Brazilian and Latin American companies that cracked Europe, and what they did differently

Brazilian and Latin American companies that cracked Europe, and what they did differently

Get your European dossier through review without losing the launch window.

  • 5 audio modulesthree lengths each
  • 50 min to 4 h 10 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Brazil and Latin America companieswho it is written for

Why this training matters

Day 120 arrives and the European Medicines Agency list of questions holds a major objection to your clinical overview. Your team rewrites it during the clock stop, the launch date moves, and the partner who was waiting starts asking why.

What changes after this course

Your regulatory, quality, clinical and business teams file, host inspections, submit value dossiers and negotiate with European rules already in their heads. Each learner finishes with a certificate, and you hold a training record per person showing who is ready.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team picks the centralized, decentralized or mutual recognition route in one meeting, with the reasons written down. They know what reviewers check at validation, so the application is complete on the day it goes in. When the list of questions arrives, the answers are already half drafted.

A quality assurance manager opens EudraLex Volume 4 and sees which of your procedures fall short before the inspector does. Annex 1 stops being a reading assignment: the contamination control strategy gets its risk assessments, and batch records are written so a Qualified Person can sign without phoning the site.

Clinical and market access leads start from one question: what will the payer ask for? They set endpoints the Committee for Medicinal Products for Human Use accepts, decide when real-world evidence belongs in the package, and know how to answer a member state that wants a lower price than your home market.

Business development managers read a European partner's redlines and can tell which clause is law and which is habit. Licensing terms and joint venture structures are settled in language a German or French legal team accepts, and your intellectual property stays protected. The term sheet stops going back and forth over the same clause.

Who needs this training

  • Head of Regulatory Affairs

    Your team argues for two days over centralized or decentralized for a new product while the filing date gets closer. You settle it in one meeting, with reasons you can show your board.

  • Quality Assurance Director

    An inspector from a European competent authority asks to see your contamination control strategy under Annex 1, and you hand over the risk assessments behind it.

  • Clinical Development Lead

    You are finishing a Phase III protocol and need to know now whether its endpoints satisfy both the review committee and the health technology assessment body, before the first patient is enrolled.

  • Market Access Manager

    A member state asks for a price below your home market. You walk into the meeting with the evidence and the answer already prepared.

  • Business Development Manager

    A German partner returns your licensing draft covered in redlines. You read them as a map of their legal limits and reply with terms that hold.

Roles: Owner, CEO and board, Business development and export sales

Businesses: every kind of pharma company

Countries: Brazil and Latin America

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the centralized, decentralized and mutual recognition procedures for a given product and write down the reasons.
  2. Assemble a marketing authorization application that is complete at validation and answer the Day 120 list of questions within the clock stop.
  3. Compare your quality manual with EudraLex Volume 4 and list the gaps an inspector would raise.
  4. Write a batch record that a Qualified Person can certify without calling the site for missing information.
  5. Build a value dossier that puts the clinical data points health technology assessment bodies look for first.
  6. Set Phase III endpoints and a patient population that the Committee for Medicinal Products for Human Use can accept.
  7. Mark up a European partner's licensing draft and identify the clauses that threaten your intellectual property.

What the company gets

  • Your marketing authorization applications reach validation complete, so the review starts when you planned it to.
  • Your manufacturing sites meet an EudraLex Volume 4 inspection with documents that already answer the inspector's questions.
  • Your clinical program produces the evidence that pricing and reimbursement authorities in your target member states ask for.
  • Your business development team brings back partnership agreements that protect your intellectual property and survive European legal review.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 5 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing50 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard2 h 05 min25 min a module, for regulatory, quality and business-development staff
Expanded4 h 10 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing50 min
Business development and export salesBriefing50 min

Course outline: 5 modules

5 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Choose the European procedure that fits your product before you file

    • How to tell in one meeting whether centralized or mutual recognition suits your product.
    • The Day 120 list of questions your dossier will draw, and how to answer it during the clock stop.
    • Why a concerned member state objects during mutual recognition, and what your file says to stop it.
  2. 2Upgrade your quality system to pass EudraLex Volume 4 inspections

    • What to fix in your quality manual before an inspector opens EudraLex Volume 4 on your site.
    • The gaps inspectors find at sites outside Europe, and the records that close them before they arrive.
    • How to write a batch record your Qualified Person can release from on the first read.
  3. 3Pass European health technology assessment with a market access plan

    • How to build a value dossier that answers the payer's first question on page one.
    • The clinical data points health technology assessment bodies check before anything else.
    • What to do when a member state asks for a price below your home market's.
  4. 4Design trial programs that European review committees accept

    • How to set Phase III endpoints that the Committee for Medicinal Products for Human Use will accept.
    • When real-world evidence strengthens your clinical package and when it only invites more questions.
    • The patient population data reviewers want to see before they agree your label.
  5. 5Secure European partnerships without tripping local deal breakers

    • Why the licensing terms you use at home make a German or French partner reach for the red pen.
    • How to structure a joint venture so your intellectual property stays yours under European law.
    • The negotiating habits that stall a distributor's legal team, and what to say instead.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

5 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 50 min in the briefing length and 4 h 10 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Brazil and Latin America companies. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 45 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team